Renbarger JL - Search Results

1

Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia.

Egbelakin A, Ferguson MJ, MacGill EA, Lehmann AS, Topletz AR, Quinney SK, Li L, McCammack KC, Hall SD, Renbarger JL. Egbelakin A, et al. Among authors: renbarger jl. Pediatr Blood Cancer. 2011 Mar;56(3):361-7. doi: 10.1002/pbc.22845. Epub 2010 Nov 11. Pediatr Blood Cancer. 2011. PMID: 21225912 Free PMC article.

2

Selective metabolism of vincristine in vitro by CYP3A5.

Dennison JB, Kulanthaivel P, Barbuch RJ, Renbarger JL, Ehlhardt WJ, Hall SD. Dennison JB, et al. Among authors: renbarger jl. Drug Metab Dispos. 2006 Aug;34(8):1317-27. doi: 10.1124/dmd.106.009902. Epub 2006 May 5. Drug Metab Dispos. 2006. PMID: 16679390

3

Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes.

Dennison JB, Jones DR, Renbarger JL, Hall SD. Dennison JB, et al. Among authors: renbarger jl. J Pharmacol Exp Ther. 2007 May;321(2):553-63. doi: 10.1124/jpet.106.118471. Epub 2007 Feb 1. J Pharmacol Exp Ther. 2007. PMID: 17272675

4

Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients.

Renbarger JL, McCammack KC, Rouse CE, Hall SD. Renbarger JL, et al. Pediatr Blood Cancer. 2008 Apr;50(4):769-71. doi: 10.1002/pbc.21435. Pediatr Blood Cancer. 2008. PMID: 18085684

5

Quantification of vincristine and its major metabolite in human plasma by high-performance liquid chromatography/tandem mass spectrometry.

Dennison JB, Renbarger JL, Walterhouse DO, Jones DR, Hall SD. Dennison JB, et al. Among authors: renbarger jl. Ther Drug Monit. 2008 Jun;30(3):357-64. doi: 10.1097/FTD.0b013e31816b92c9. Ther Drug Monit. 2008. PMID: 18520608

6

Collection of human genomic DNA from neonates: a comparison between umbilical cord blood and buccal swabs.

Lehmann AS, Haas DM, McCormick CL, Skaar TC, Renbarger JL. Lehmann AS, et al. Among authors: renbarger jl. Am J Obstet Gynecol. 2011 Apr;204(4):362.e1-6. doi: 10.1016/j.ajog.2010.12.013. Epub 2011 Feb 16. Am J Obstet Gynecol. 2011. PMID: 21324432 Free PMC article.

7

A pilot study of the impact of genotype on nifedipine pharmacokinetics when used as a tocolytic.

Haas DM, Quinney SK, McCormick CL, Jones DR, Renbarger JL. Haas DM, et al. Among authors: renbarger jl. J Matern Fetal Neonatal Med. 2012 Apr;25(4):419-23. doi: 10.3109/14767058.2011.583700. Epub 2011 Jun 7. J Matern Fetal Neonatal Med. 2012. PMID: 21644845 Clinical Trial.

8

Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients.

Yancey A, Harris MS, Egbelakin A, Gilbert J, Pisoni DB, Renbarger J. Yancey A, et al. Pediatr Blood Cancer. 2012 Jul 15;59(1):144-8. doi: 10.1002/pbc.24138. Epub 2012 Mar 19. Pediatr Blood Cancer. 2012. PMID: 22431292 Free PMC article. Clinical Trial.

9

Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolytic.

Haas DM, Quinney SK, Clay JM, Renbarger JL, Hebert MF, Clark S, Umans JG, Caritis SN; Obstetric-Fetal Pharmacology Research Units Network. Haas DM, et al. Among authors: renbarger jl. Am J Perinatol. 2013 Apr;30(4):275-81. doi: 10.1055/s-0032-1323590. Epub 2012 Aug 8. Am J Perinatol. 2013. PMID: 22875663 Free PMC article.

10

The tumor suppressor CDKN3 controls mitosis.

Nalepa G, Barnholtz-Sloan J, Enzor R, Dey D, He Y, Gehlhausen JR, Lehmann AS, Park SJ, Yang Y, Yang X, Chen S, Guan X, Chen Y, Renbarger J, Yang FC, Parada LF, Clapp W. Nalepa G, et al. J Cell Biol. 2013 Jun 24;201(7):997-1012. doi: 10.1083/jcb.201205125. Epub 2013 Jun 17. J Cell Biol. 2013. PMID: 23775190 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page